Figure 3 shows the distribution of serum KL‐6 level in SYSTEM A and SYSTEM B among the various subject groups, ILD and non‐ILD groups (including patients with lung cancer and other respiratory diseases and healthy controls). Here, MUC1 is linked to lung carcinoma.